Ameriprise’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.81M | Buy |
39,255
+18,201
| +86% | +$4.53M | ﹤0.01% | 1942 |
|
|
2025
Q4 | $5.79M | Sell |
21,054
-1,615
| -7% | -$442K | ﹤0.01% | 2335 |
|
|
2025
Q3 | $5.95M | Sell |
22,669
-147,266
| -87% | -$35.8M | ﹤0.01% | 2309 |
|
|
2025
Q2 | $37.2M | Sell |
169,935
-4,503
| -3% | -$963K | 0.01% | 1019 |
|
|
2025
Q1 | $39.1M | Buy |
174,438
+6,692
| +4% | +$1.84M | 0.01% | 953 |
|
|
2024
Q4 | $54.9M | Buy |
167,746
+29,118
| +21% | +$9.16M | 0.01% | 793 |
|
|
2024
Q3 | $41.6M | Sell |
138,628
-117,693
| -46% | -$36M | 0.01% | 929 |
|
|
2024
Q2 | $84.4M | Sell |
256,321
-23,183
| -8% | -$8.19M | 0.02% | 587 |
|
|
2024
Q1 | $111M | Sell |
279,504
-27,797
| -9% | -$10.3M | 0.03% | 497 |
|
|
2023
Q4 | $108M | Buy |
307,301
+14,627
| +5% | +$5.18M | 0.03% | 493 |
|
|
2023
Q3 | $110M | Sell |
292,674
-30,623
| -9% | -$11.8M | 0.04% | 459 |
|
|
2023
Q2 | $124M | Sell |
323,297
-228,253
| -41% | -$81.5M | 0.04% | 436 |
|
|
2023
Q1 | $191M | Buy |
551,550
+20,009
| +4% | +$5.85M | 0.06% | 309 |
|
|
2022
Q4 | $125M | Buy |
531,541
+457,605
| +619% | +$108M | 0.04% | 413 |
|
|
2022
Q3 | $18.5M | Sell |
73,936
-4,795
| -6% | -$1.46M | 0.01% | 1221 |
|
|
2022
Q2 | $23.4M | Sell |
78,731
-19,424
| -20% | -$6.32M | 0.01% | 1110 |
|
|
2022
Q1 | $39.6M | Sell |
98,155
-9,658
| -9% | -$3.78M | 0.01% | 914 |
|
|
2021
Q4 | $48.5M | Buy |
107,813
+52,360
| +94% | +$22.5M | 0.01% | 861 |
|
|
2021
Q3 | $23.9M | Sell |
55,453
-69,486
| -56% | -$29.3M | 0.01% | 1138 |
|
|
2021
Q2 | $44.9M | Buy |
124,939
+12,280
| +11% | +$4.06M | 0.01% | 846 |
|
|
2021
Q1 | $31.7M | Sell |
112,659
-240,757
| -68% | -$68.9M | 0.01% | 1008 |
|
|
2020
Q4 | $100M | Buy |
353,416
+14,346
| +4% | +$4.03M | 0.04% | 469 |
|
|
2020
Q3 | $93.2M | Buy |
339,070
+54,276
| +19% | +$14.4M | 0.04% | 446 |
|
|
2020
Q2 | $64.7M | Sell |
284,794
-169,864
| -37% | -$33.4M | 0.03% | 530 |
|
|
2020
Q1 | $69.2M | Buy |
454,658
+69,178
| +18% | +$10.6M | 0.04% | 447 |
|
|
2019
Q4 | $57.9M | Buy |
385,480
+3,200
| +0.8% | +$466K | 0.02% | 635 |
|
|
2019
Q3 | $54.1M | Buy |
382,280
+60,593
| +19% | +$8.34M | 0.02% | 618 |
|
|
2019
Q2 | $40.3M | Sell |
321,687
-1,892
| -0.6% | -$223K | 0.02% | 782 |
|
|
2019
Q1 | $35.7M | Sell |
323,579
-10,260
| -3% | -$1.07M | 0.02% | 810 |
|
|
2018
Q4 | $32.7M | Sell |
333,839
-28,480
| -8% | -$3.09M | 0.02% | 795 |
|
|
2018
Q3 | $44.7M | Sell |
362,319
-678
| -0.2% | -$76K | 0.02% | 807 |
|
|
2018
Q2 | $36M | Sell |
362,997
-15,979
| -4% | -$1.47M | 0.02% | 825 |
|
|
2018
Q1 | $33.5M | Sell |
378,976
-161,812
| -30% | -$15.1M | 0.02% | 851 |
|
|
2017
Q4 | $53.4M | Sell |
540,788
-63,053
| -10% | -$6.18M | 0.02% | 560 |
|
|
2017
Q3 | $58.1M | Buy |
603,841
+28,432
| +5% | +$2.57M | 0.03% | 524 |
|
|
2017
Q2 | $54.4M | Buy |
575,409
+174,400
| +43% | +$16M | 0.03% | 526 |
|
|
2017
Q1 | $32.7M | Buy |
401,009
+10,478
| +3% | +$876K | 0.02% | 709 |
|
|
2016
Q4 | $33.1M | Buy |
390,531
+120,411
| +45% | +$9.47M | 0.02% | 696 |
|
|
2016
Q3 | $20.1M | Sell |
270,120
-7,215
| -3% | -$573K | 0.01% | 943 |
|
|
2016
Q2 | $21M | Sell |
277,335
-43,509
| -14% | -$3.17M | 0.01% | 872 |
|
|
2016
Q1 | $22.2M | Buy |
320,844
+19,049
| +6% | +$1.15M | 0.01% | 846 |
|
|
2015
Q4 | $18.2M | Sell |
301,795
-18,856
| -6% | -$1.13M | 0.01% | 975 |
|
|
2015
Q3 | $17.4M | Sell |
320,651
-255,400
| -44% | -$14.9M | 0.01% | 1032 |
|
|
2015
Q2 | $33.5M | Sell |
576,051
-15,342
| -3% | -$856K | 0.02% | 697 |
|
|
2015
Q1 | $35.6M | Sell |
591,393
-30,263
| -5% | -$1.61M | 0.02% | 674 |
|
|
2014
Q4 | $33.1M | Sell |
621,656
-44,395
| -7% | -$2.22M | 0.02% | 695 |
|
|
2014
Q3 | $29.8M | Sell |
666,051
-5,039
| -0.8% | -$214K | 0.02% | 739 |
|
|
2014
Q2 | $28.3M | Buy |
671,090
+25,790
| +4% | +$1.1M | 0.02% | 825 |
|
|
2014
Q1 | $28.4M | Sell |
645,300
-111,452
| -15% | -$5.25M | 0.02% | 807 |
|
|
2013
Q4 | $37.1M | Buy |
756,752
+13,946
| +2% | +$653K | 0.02% | 661 |
|
|
2013
Q3 | $30.6M | Sell |
742,806
-91,176
| -11% | -$3.48M | 0.02% | 770 |
|
|
2013
Q2 | $29.3M | Buy |
+833,982
| New | +$27.4M | 0.02% | 768 |
|
Other funds holding WST
VCM
VPM
GIM
Ameriprise's WST Position: Q1 2026 in Review
Ameriprise increased its West Pharmaceutical (WST) stake by 86% in Q1 2026, buying an estimated $4.53M and bringing the position to 39,255 shares worth $9.81M. The position accounts for ﹤0.01% of the portfolio, ranked #1942.
Ameriprise first reported a position in WST in Q2 2013 and has held it in 52 quarters since. The position peaked at $191M in Q1 2023. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.
- Ameriprise held 39,255 shares of West Pharmaceutical worth $9.81M as of Q1 2026.
- Ameriprise bought 18,201 West Pharmaceutical shares in Q1 2026, an estimated $4.53M.
- West Pharmaceutical made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #1942 holding.
- Ameriprise first reported a position in West Pharmaceutical in Q2 2013 and has held it in 52 quarters since.
- Ameriprise's West Pharmaceutical position peaked at $191M in Q1 2023.
- 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.